• Syndax Pharmaceuticals director Dennis Podlesak sold 8,000 shares of common stock at $14.2145 per share on Oct. 29, 2026.
• He exercised stock options to acquire 8,000 shares at $11.81 per share the same day.
• His direct common stock holdings totaled 239,763 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-442119), on October 30, 2026, and is solely responsible for the information contained therein.